ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Controversies in the treatment of aortic valve disease
Mon 02 Sep 14:30 - 15:40 Valvular Heart Disease – Treatment Debate Session, Mobile App - Ask a Question Duras - The Hub
Chairpersons: Julia MASCHERBAUER (Vienna, Austria), Ottavio ALFIERI (Milano, Italy)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:304004Pure aortic regurgitation remains off-limits for TAVI - PROThierry FOLLIGUET (Creteil, France)
14:434005Pure aortic regurgitation remains off-limits for TAVI - CONRaj MAKKAR (Los Angeles, United States of America)
14:564006Pure aortic regurgitation remains off-limits for TAVI - Discussion 
15:054007Valve-in-valve TAVI regardless of risk profile - PRODanny DVIR (Vancouver, Canada)
15:184008Valve-in-valve TAVI regardless of risk profile - CONGino GEROSA (Padova, Italy)
15:31 Valve-in-valve TAVI regardless of risk profile - Discussion